H
Hawthorne Effect
Operates a nationwide network and technology platform to deliver decentralized, community-based clinical trials
About Hawthorne Effect
Hawthorne Health is a clinical research network focused on expanding access to clinical trials by integrating research into community healthcare settings and patients’ homes. With a network of 75 community-based sites across the United States, the company aims to eliminate traditional barriers to trial participation, such as geographic distance and lack of trust, by embedding research in familiar environments. This approach increases patient enrollment, retention, and compliance, while also ensuring data collection is representative of diverse populations.
The company leverages experienced investigators, research nurses, and advanced technology to streamline trial operations and maximize outcomes. Hawthorne Health covers a broad range of therapeutic areas, including cardiovascular, dermatology, gastroenterology, immunology, infectious disease, metabolic, neurology, pediatrics, psychiatry, rare disease, and respiratory/pulmonology. Its home visit solution allows complex assessments and study visits to be conducted in patients’ homes, further reducing barriers and supporting inclusion.
Hawthorne Health collaborates with sponsors and partners to deliver high-quality, protocol-compliant data, supporting transformative breakthroughs in medicine. The company’s model is recognized for driving diversity in research and enabling real-world evidence generation that reflects the broader patient population.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Walnut Creek, United States
- Employees
- 177
- Open positions
- None listed
- Dealroom signal
- 86.2/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Health Care Information Technology, Healthcare Services, Healthcare IT Management, Patient Care, Patient Engagement, Disease, Remote Patient Care
- Business model
- SaaS
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2021 | $20M | $80M | Northpond Ventures · SignalFire · P5 Health Ventures | — |
| CONVERTIBLEEquity / VC | Jan 2020 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Hawthorne Effect is 7.3K monthly website visits, up 43.1% over the last three months. Hawthorne Effect's team grew 16.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A2 investors entered at this stage
Northpond Ventures
P5 Health Ventures
Other known investors3 additional known investors
Astia
Biovision Ventures
Tech Coast Angels
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hawthorne Effect on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hawthorne Effect’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








